Analysis of Segmental Duplications, Mouse Genome Synteny and Recurrent Cancer-Associated Amplicons in Human Chromosome 6p21–p12
Jeff W. Martin, Paulo Nuin(Queen's University), Olga Ludkovski, Jeremy A. Squire(Universidade de São Paulo), Paul S. Thorner(University of Toronto), Maisa Yoshimoto(University of Alberta), Maria Zieleńska(University of Toronto)
Cited by 16
Related Papers
FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome
|British Journal of Cancer|2007|294
Cause and Consequences of Genetic and Epigenetic Alterations in Human Cancer
|Current Genomics|2008|293
Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome
|Modern Pathology|2008|278
<i>PTEN</i> genomic deletion is associated with p‐Akt and AR signalling in poorer outcome, hormone refractory prostate cancer
|The Journal of Pathology|2009|210